TerminatedPhase 4NCT00711841
Effectivity of Postpartum Dexamethasone for Women With Class I HELLP Syndrome
Studying HELLP syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Instituto Materno Infantil Prof. Fernando Figueira
- Principal Investigator
- Leila Katz, pHDIMIP
- Intervention
- dexamethasone(drug)
- Enrollment
- 400 target
- Eligibility
- 13-49 years · FEMALE
- Timeline
- 2011 – 2019
Study locations (1)
- Instituto Materno Infantil Prof. Fernando Figueira, Recife, Pernambuco, Brazil
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00711841 on ClinicalTrials.govOther trials for HELLP syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07151339Pilot Project Renal and Cardiovascular Tertiary Prevention in PreeclampsiaUniversity Hospital Schleswig-Holstein
- RECRUITINGNCT05500989PlacEntal Acute Atherosis RefLecting Subclinical AtherosclerosisMaastricht University Medical Center
- RECRUITINGNCT06377878The Preeclampsia RegistryPreeclampsia Foundation